Defiance Daily Target 2X Short LLY ETF (LLYZ)
| Assets | $1.48M |
| Expense Ratio | 1.29% |
| PE Ratio | n/a |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 40,269 |
| Open | 8.73 |
| Previous Close | n/a |
| Day's Range | 8.53 - 8.76 |
| 52-Week Low | 7.63 |
| 52-Week High | 21.15 |
| Beta | n/a |
| Holdings | 9 |
| Inception Date | Sep 2, 2025 |
About LLYZ
The Defiance Daily Target 2X Short LLY ETF (LLYZ) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x inverse leveraged exposure to the daily share price movement of Eli Lilly and Company (NASDAQ: LLY), less fees and expenses, through derivatives like swap agreements. LLYZ was launched on Sep 2, 2025 and is issued by Defiance.
News
Defiance ETFs Announces Closure of Select Funds
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate eight exchange-traded funds listed on the Nasdaq: Defiance Lev...
Defiance Launches LLYZ: The First 2X Short ETF for Eli Lilly
MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Short LLY ETF (Ticker: LLY...